Health Catalyst Stock Performance
| HCAT Stock | USD 3.89 0.10 2.51% |
Health Catalyst has a performance score of 1 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 1.42, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Health Catalyst will likely underperform. Health Catalyst right now retains a risk of 3.32%. Please check out Health Catalyst coefficient of variation, semi variance, price action indicator, as well as the relationship between the treynor ratio and daily balance of power , to decide if Health Catalyst will be following its current trending patterns.
Risk-Adjusted Performance
Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Health Catalyst are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Health Catalyst is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors. ...more
Actual Historical Performance (%)
One Day Return (2.51) | Five Day Return (2.75) | Year To Date Return (47.00) | Ten Year Return (90.07) | All Time Return (90.07) |
1 | Health Catalyst to Announce First Quarter 2025 Operating Results and Host Conference Call on Wednesday, May 7, 2025 | 04/17/2025 |
2 | Health Catalyst Surpasses Q1 Revenue and Earnings Projections HCAT Stock News | 05/07/2025 |
3 | Disposition of 5209 shares by Daniel LeSueur of Health Catalyst at 5.7607 subject to Rule 16b-3 | 05/16/2025 |
4 | Health Catalysts SWOT analysis ignite platform fuels stock growth hopes - Investing.com | 05/22/2025 |
5 | Acquisition by Gallagher Duncan of 4080 shares of Health Catalyst subject to Rule 16b-3 | 05/30/2025 |
6 | Disposition of 2965 shares by Linda Llewelyn of Health Catalyst at 3.6348 subject to Rule 16b-3 | 06/02/2025 |
7 | Disposition of 3255 shares by Benjamin Landry of Health Catalyst at 3.6348 subject to Rule 16b-3 | 06/03/2025 |
8 | Disposition of 6057 shares by Benjamin Landry of Health Catalyst at 3.9443 subject to Rule 16b-3 | 06/05/2025 |
9 | Stifel maintains Health Catalyst stock Hold rating, 5.50 target By Investing.com - Investing.com India | 06/09/2025 |
10 | Insider Selling Health Catalyst, Inc. General Counsel Sells 6,057 Shares of Stock | 06/11/2025 |
11 | Insider Trading | 06/13/2025 |
12 | Health Catalyst Faces Downgrade Amid Financial Pressures HCAT Stock News | 06/17/2025 |
13 | Accelerating Measurable Improvement Through Actionable Insights Health Catalyst Announces the ... | 07/01/2025 |
14 | Health Catalyst Evercore ISI Group Updates Price Target HCAT Stock News | 07/09/2025 |
| Begin Period Cash Flow | 106.3 M | |
| Free Cash Flow | -1.8 M |
Health Catalyst Relative Risk vs. Return Landscape
If you would invest 384.00 in Health Catalyst on April 14, 2025 and sell it today you would earn a total of 5.00 from holding Health Catalyst or generate 1.3% return on investment over 90 days. Health Catalyst is currently generating 0.0745% in daily expected returns and assumes 3.3216% risk (volatility on return distribution) over the 90 days horizon. In different words, 29% of stocks are less volatile than Health, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Health Catalyst Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Health Catalyst's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Health Catalyst, and traders can use it to determine the average amount a Health Catalyst's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0224
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | HCAT | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.32 actual daily | 29 71% of assets are more volatile |
Expected Return
| 0.07 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Health Catalyst is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Health Catalyst by adding it to a well-diversified portfolio.
Health Catalyst Fundamentals Growth
Health Stock prices reflect investors' perceptions of the future prospects and financial health of Health Catalyst, and Health Catalyst fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Health Stock performance.
| Return On Equity | -0.2 | ||||
| Return On Asset | -0.0415 | ||||
| Profit Margin | (0.23) % | ||||
| Operating Margin | (0.17) % | ||||
| Current Valuation | 331.15 M | ||||
| Shares Outstanding | 69.6 M | ||||
| Price To Earning | (2.62) X | ||||
| Price To Book | 0.72 X | ||||
| Price To Sales | 0.89 X | ||||
| Revenue | 306.58 M | ||||
| Gross Profit | 143 M | ||||
| EBITDA | (27.1 M) | ||||
| Net Income | (69.5 M) | ||||
| Cash And Equivalents | 403.35 M | ||||
| Cash Per Share | 7.37 X | ||||
| Total Debt | 402.26 M | ||||
| Debt To Equity | 0.53 % | ||||
| Current Ratio | 5.15 X | ||||
| Book Value Per Share | 5.42 X | ||||
| Cash Flow From Operations | 14.56 M | ||||
| Earnings Per Share | (1.15) X | ||||
| Market Capitalization | 277.71 M | ||||
| Total Asset | 858.93 M | ||||
| Retained Earnings | (1.19 B) | ||||
| Working Capital | 139.8 M | ||||
| Current Asset | 216.75 M | ||||
| Current Liabilities | 48.69 M | ||||
About Health Catalyst Performance
Assessing Health Catalyst's fundamental ratios provides investors with valuable insights into Health Catalyst's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Health Catalyst is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.14) | (0.14) | |
| Return On Capital Employed | (0.13) | (0.14) | |
| Return On Assets | (0.08) | (0.08) | |
| Return On Equity | (0.19) | (0.20) |
Things to note about Health Catalyst performance evaluation
Checking the ongoing alerts about Health Catalyst for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Health Catalyst help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Health Catalyst had very high historical volatility over the last 90 days | |
| Health Catalyst has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 306.58 M. Net Loss for the year was (69.5 M) with profit before overhead, payroll, taxes, and interest of 143 M. | |
| Over 82.0% of the company shares are owned by institutional investors | |
| Latest headline from gurufocus.com: Health Catalyst Evercore ISI Group Updates Price Target HCAT Stock News |
- Analyzing Health Catalyst's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Health Catalyst's stock is overvalued or undervalued compared to its peers.
- Examining Health Catalyst's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Health Catalyst's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Health Catalyst's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Health Catalyst's stock. These opinions can provide insight into Health Catalyst's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Health Stock Analysis
When running Health Catalyst's price analysis, check to measure Health Catalyst's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Health Catalyst is operating at the current time. Most of Health Catalyst's value examination focuses on studying past and present price action to predict the probability of Health Catalyst's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Health Catalyst's price. Additionally, you may evaluate how the addition of Health Catalyst to your portfolios can decrease your overall portfolio volatility.